High ionic strength may disable skin antimicrobial peptides and sustain dermal damage
In a human skin model, high ionic strength may weaken secreted antimicrobial peptides despite normal water loss. The hypothesis is rejected if the measured salt composition does not reduce peptide activity or normalizing it does not improve bacterial killing.
Stage of verification
- Hypothesis published2026-09-25
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Signalling molecule
Antimicrobial peptides
Secreted peptides that kill bacteria or suppress their growth
Where this hypothesis actsOn the skin surface after dryness, washing and friction, under elevated ionic strength
Hypotheses on this target 1
Lower level
Synthesis suppression
Neutralisation
Supplementation
Accelerated excretion
What is proposed
Restore antimicrobial activity by normalizing ionic strength
With whatChange of environment or regimen
HowReplace the surrounding salt composition under controlled conditions while preserving protein concentrations and leaving peptide secretion unchanged
Possible result
Possible reduction in viable microbial load and dermal damage, with stabilization of SPV_6
From the recordПри одинаковых потере воды, липидном составе, кислотности и количестве секретированных пептидов противомикробная активность должна восстанавливаться после нормализации ионной силы без усиления секреции.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Skin that holds water normally may still struggle to control bacteria after repeated dryness, washing and friction. The unexpected move is that several protective molecules could remain present in normal amounts yet lose activity together because of their chemical surroundings. This is a proposal generated by the pipeline, not a measured explanation of declining skin function in middle age.
- Dryness, washing and friction are proposed to leave the skin surface with elevated ionic strength.
- That shared chemical environment is proposed to turn several normally present protective peptides from effective bacterial killers into weak ones, without reducing their production or release.
- Replacement of skin fats is proposed to restore water retention while potentially leaving the inhibitory salt conditions unchanged.
- Weakened peptide activity is proposed to let the number of living microbes remain elevated.
- Persistent microbes are proposed to sustain injury in the deeper skin layer.
- Correcting the salt conditions is predicted to restore killing before living microbe numbers and deeper injury decline.
Several battery-powered lamps can all be present and switched on yet grow dim in the same cold room. Adding more lamps with the same vulnerability may help less than changing the room conditions or using a lamp that works there.
Where the picture breaks: Peptides do not behave like lamps: their combined effects can strengthen or weaken one another, and salt can also affect bacteria directly. The picture explains a shared vulnerability but does not establish that it occurs on skin.
- Master questionstep 01 of 04
The goal is a treatment that brings the functional condition of middle-aged human skin closer to that of young people.
Rests on: The supplied goal defines the desired outcome, without specifying which functions would establish that it had been reached.
Stated in the chain - Goal pillarstep 02 of 04
Limiting damage that accumulates through repeated repair is selected as a route toward younger skin function.
Rests on: The preceding goal supplies the desired improvement but does not connect it to cumulative damage from repeated repair.
LeapThe supplied chain does not establish that repeated repair produces cumulative damage responsible for the functional difference between middle-aged and young skin.
- Gap questionstep 03 of 04
Restoring the skin’s resistance to water loss might leave its defense against microbes impaired, allowing injury to continue in the dermis, the deeper skin layer. The alternative raised here is a shared defect in releasing lipids, the fats involved in the surface barrier, and protective substances that act against microbes.
Rests on: The preceding stage identifies repeated repair as the concern but supplies no specific connection between water retention, release of protective substances and deeper skin injury.
LeapThe missing bridge is evidence or an explicit rationale linking cumulative repair damage to a separation between recovery of water retention and recovery of protection against microbes.
- Hypothesisstep 04 of 04
Elevated ionic strength, a measure of the concentration and electrical charges of dissolved ions, is proposed to weaken several antimicrobial peptides, short protein molecules that kill or inhibit microbes. Their amounts, maturation into active forms and secretion, meaning release from cells, would remain normal. Replacing skin fats could restore water retention while leaving this chemical inhibition in place, allowing microbes to sustain deeper injury.S5S8
Rests on: The preceding question supplies the possibility of impaired microbial defense despite normal water loss. Antimicrobial Agents and Chemotherapy (1998, S5) found that LL-37, a human antimicrobial peptide, lost effectiveness against certain organisms in salt-containing laboratory media; it did not establish simultaneous inhibition of several peptides or injury in recovering skin. PLOS ONE (2009, S8) supports salt sensitivity of electrically driven binding and killing by the peptides it studied, but does not establish the proposed sequence in skin.
Supported by literature
What is carried, and what is not. Screened sources directly support part of one proposed link: salt conditions can weaken the activity of some peptides, as reported in Antimicrobial Agents and Chemotherapy (1998, S5) and PLOS ONE (2009, S8), without establishing the relevant surface conditions or the downstream injury. The supplied abstracts in The Journal of Biological Chemistry (2001, S6) and Journal of Immunology (2009, S7) also report protective molecules retaining activity under the salt conditions tested, limiting any generalization across skin defenses; no supplied source establishes the sequence end to end.S5S8S6S7
Where the reasoning is carried by something unstated · 2
- Goal pillar. The supplied chain does not establish that repeated repair produces cumulative damage responsible for the functional difference between middle-aged and young skin. Establish the missing link before relying on this step.
- Gap question. The missing bridge is evidence or an explicit rationale linking cumulative repair damage to a separation between recovery of water retention and recovery of protection against microbes. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Improved bacterial control after changing salts could reflect a direct effect on bacterial growth or a change in water movement across cell boundaries, rather than restored peptide activity. What closes it: The proposed controls must separately measure bacterial growth without the peptides and compare an electrically uncharged substance that produces a comparable effect on water movement. Protein concentration, acidity, skin-fat composition and water loss must remain matched as specified.
- Restored killing in a cell-free sample, a preparation without skin cells, could be mistaken for proof that peptide inhibition caused deeper skin injury. The rival explanation allows bacteria to benefit from replacement fats even when peptide activity is intact. What closes it: The human-skin model must measure peptide killing activity, living microbe numbers and deeper injury separately, establishing the predicted order of recovery. Equal fat composition alone does not establish equal bacterial use of those fats; that use must be measured or independently controlled to distinguish the rival route.
- A reported improvement in SPV_6, an outcome identifier left undefined in the supplied material, could be mistaken for demonstrated recovery of skin function. A negative result could also be blamed on the mechanism when the intervention never restored peptide activity at the skin surface. What closes it: The work must define SPV_6, its measurement and the criterion for stabilization before testing, and verify the intended salt change and recovery of peptide activity in the skin model. The supplied material provides neither an operational definition of SPV_6 nor a numerical range for acceptable water loss.
What would make this wrong. The hypothesis’s own stated falsifiers are that the measured salt composition does not suppress peptide activity, or that normalizing it does not improve bacterial killing under the specified matched conditions. The complete damage mechanism would also fail if verified recovery of peptide activity did not produce the predicted subsequent reduction in living microbes and deeper skin injury in the tested model. No supplied result establishes these outcomes.
What it would change. If the proposed sequence held, restoring water retention alone would be insufficient to establish recovery of skin defense after repeated disturbance. Work toward improving middle-aged skin would need to distinguish protective molecules being present from their remaining active in the surface environment. Even a successful human-skin model would leave unestablished whether this mechanism explains functional decline in middle-aged people, whether correcting it lasts through repeated repair, and whether it restores the functions characteristic of young skin.
Sources read · 8
Degradable dendritic nanogels as carriers for antimicrobial peptides. · Journal of colloid and interface science · 2019
“While 40-60% nanogel degradation occurred over 10 days, promoted at high ionic strength and lower cross-linking density/higher anionic charge content, peptide release at physiological ionic strength was substantially faster, and membrane destabilization not relying on nanogel degradation.”
Does not settle: This abstract does not test skin surface conditions, endogenous peptide abundance, processing or secretion, bacterial control by multiple peptides at high ionic strength, lipid correction, dermal damage, or SPV_6.
Engineering poly(dehydroalanine)-based gels via droplet-based microfluidics: from bulk to microspheres. · Soft matter · 2024
“We demonstrate pH-regulated uptake and release of fluorescent model dyes before testing the adsorption of a small antimicrobial peptide, LL-37.”
Does not settle: Текст не устанавливает влияние ионной силы на бактерицидную активность кожных противомикробных пептидов, их количество, созревание или секрецию, микробную нагрузку, повреждение дермы, потерю воды или эффект липидной коррекции.
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. · Antimicrobial agents and chemotherapy · 1998
“Certain organisms (methicillin-resistant S. aureus , Proteus mirabilis , and Candida albicans ) were resistant to LL-37 in media that contained 100 mM NaCl but were susceptible in low-salt media.”
Does not settle: Источник показывает солезависимую потерю активности LL-37 in vitro для некоторых микроорганизмов. Он не устанавливает состояние поверхности кожи после сухости, мытья и трения, одновременное подавление нескольких пептидов, нормальность их количества, созревания и секреции, влияние липидной коррекции, сохранение микробной нагрузки, повреждение дермы или стабилизацию SPV_6.
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. · The Journal of biological chemistry · 2001
“hBD-3 demonstrated a salt-insensitive broad spectrum of potent antimicrobial activity against many potentially pathogenic microbes including multiresistant S. aureus and vancomycin-resistant Enterococcus faecium.”
Does not settle: This abstract does not establish effects of ionic strength on other skin antimicrobial peptides, the effects of dryness, washing, friction or lipid correction, peptide abundance or secretion, microbial persistence, dermal damage, or SPV_6.
Potent and broad-spectrum antimicrobial activity of CXCL14 suggests an immediate role in skin infections. · Journal of immunology (Baltimore, Md. : 1950) · 2009
“Increased salt concentrations and skin-typical pH conditions did not abrogate its AMP function.”
Does not settle: Источник оценивает CXCL14, а не несколько секретируемых пептидов; не устанавливает влияние сухости, мытья, трения, липидной коррекции, потери воды, микробной нагрузки, повреждения дермы или SPV_6.
End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. · PloS one · 2009
“Additionally, electrostatically driven peptide binding is salt sensitive, and bactericidal potency of such peptides at physiological ionic strength limited.”
Does not settle: Источник не исследует поверхность кожи после сухости, мытья и трения, несколько секретируемых пептидов кожи, их количество, созревание или секрецию, липидную коррекцию, потерю воды, микробную нагрузку, повреждение дермы или SPV_6.
Engineered Lysin-Derived Peptide as a Potent Antimicrobial for Acne Vulgaris. · Antibiotics (Basel, Switzerland) · 2025
“Additionally, P156 maintained its potency under conditions (e.g., temperature, pH, and salt concentration) observed on the skin surface and in hair follicles”
Does not settle: Источник описывает один инженерный лизин-производный пептид в испытаниях in vitro, а не секретируемые противомикробные пептиды кожи. Он не устанавливает, снижает ли повышенная ионная сила активность нескольких эндогенных пептидов, при нормальных ли их количестве, созревании и секреции это происходит, и не рассматривает сухость, мытьё, трение, потерю воды, липидную коррекцию, микробную нагрузку, повреждение дермы или SPV_6.
The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin in vitro. · Frontiers in immunology · 2022
“LL-37 shows direct antimicrobial activity against a wide variety of microorganisms, including Gram-negative and Gram-positive bacteria, viruses, and fungi ( – ), although its antimicrobial effects decrease under physiological concentrations of salt, divalent cations, host lipids, glycosaminoglycans, and lipoproteins ( – ).”
Does not settle: Источник оставляет открытыми применимость к поверхности кожи и дерме, роль нескольких противомикробных пептидов, влияние сухости, мытья и трения, сохранность количества, созревания и секреции пептидов, эффект липидной коррекции, микробную нагрузку и показатель SPV_6.
The gap this hypothesis explains
What is measured here stands in for what matters, and may not track it.
Does restoring skin’s water barrier stop deeper damage, or can faulty secretion leave immune defenses weakened?
Original wording · exactly as the pipeline generated it
Устраняет ли восстановление водного барьера распространение повреждения в дерму, или общий дефект секреции липидов и противомикробных факторов сохраняет иммунную уязвимость при нормальной потере воды?
What this question is asking
The question concerns whether skin that retains water normally has also recovered its protection against further injury. It asks whether restoring the water barrier stops damage from spreading into the dermis, the deeper skin layer, or whether impaired release of fats and substances that fight microbes leaves immune protection weakened. The decisive comparison is between recovery of water retention and recovery of deeper tissue and immune protection after treatment. The question assumes that a shared secretion defect could underlie both water loss and weakened defenses, so correcting water loss might leave that defect unresolved. The intended setting is middle-aged human skin, but the supplied findings concern particular skin diseases, experimental injury, and measurements of barrier function.
- Water barrier and water loss
- The water barrier is the skin's ability to restrict water escaping through it. Water loss measures that outward escape; normal water retention is the proposed sign of recovery, but the input provides no numerical definition of normal.
- Dermis
- The skin layer beneath the epidermis, or outer skin layer. The question asks whether injury continues into this deeper tissue after water retention recovers.
- Secretion
- The release of materials from cells or glands. Producing a substance and releasing it are different steps, so evidence of reduced production does not by itself establish a secretion defect.
- Lipids
- A class of fatty substances, including materials involved in the skin's water barrier. The question concerns whether their release shares a defect with release of substances involved in protection against microbes.
- Antimicrobial factors and antimicrobial peptides
- Antimicrobial factors are substances involved in defense against microbes, such as bacteria and fungi. Antimicrobial peptides are short protein-like molecules within that broad class; changes in them do not alone measure the entirety of immune protection.
- Immune vulnerability
- Reduced ability of the body's defenses to limit harmful challenges. Here it is an outcome that might remain abnormal after water retention improves, rather than a condition directly demonstrated by the supplied findings.
- Inflammation
- A tissue response involving immune activity. Its reduction is one reported treatment outcome, but it is distinct from demonstrating restored protection against microbes.
- Rosacea and papulopustular rosacea
- Rosacea is an inflammatory skin condition; papulopustular rosacea is a form with raised bumps and pus-containing spots. The human samples and mouse models described here concern this disease setting rather than ordinary skin aging.
- Hyaluronan
- A chain-forming sugar-based molecule. S2 concerns treatment with short pieces of those chains, called oligosaccharides.
- Filaggrin
- A protein associated with the outer skin barrier. Its increase accompanies reduced water loss in S2, but that finding does not establish recovery of immune protection.
- Atopic dermatitis
- An inflammatory skin condition also called atopic eczema. S7 studies an experimentally induced version in mice, while S8 discusses it in relation to stress.
- Lamellar bodies
- Small structures within skin cells involved in releasing materials for the outer barrier. S8 reports reduced secretion from them, and S7 describes a treatment system intended to mimic them.
- Antibody
- A protein produced by the immune system. A decrease in the antibody measurement reported in S7 is an immune-related change, not a direct demonstration that protection against microbes has recovered.
A shared defect in secretion of lipids and antimicrobial factors may cause both impaired water retention and immune vulnerability, with vulnerability potentially persisting after water loss returns to normal.
Lipids are fats involved in the skin barrier, and antimicrobial factors are substances that help defend against microbes; secretion is their release from cells or glands. The assumption is that a common failure in releasing these protective materials could affect both water retention and immune protection. If that failure persisted after water loss improved, the water measurement alone would not establish complete recovery.
S4 reports changes in both structural barrier components and antimicrobial peptides in rosacea samples. S8 reports decreased secretion from lamellar bodies alongside reduced production of antimicrobial peptides, but reduced production is not itself proof of defective secretion of those peptides. These findings support linked disturbances in barrier and protective components, a narrower claim than a single shared secretion defect. S9 describes water loss as a measure of outward barrier function; none of these sources establishes persistent immune vulnerability after water loss has normalized.S4S8S9
The same question asked without the part nothing read establishes:
- After water loss returns to normal in middle-aged human skin, does deeper tissue damage stop, and is protection against microbes restored?
- Does normal water loss coincide with restored release of skin lipids and antimicrobial substances?
- Water retention and protection recover together If the intervention corrects the failure responsible for both water leakage and weakened protection, improved retention would accompany restored defenses and cessation of deeper damage. In that setting, normal water loss would coincide with broader recovery, although coincidence alone would not establish that water retention caused the other improvements.
- Water retention recovers but vulnerability persists If water retention improves while release of protective substances remains impaired, the water measurement would record recovery of only one function. Persistent immune vulnerability would mean that normal water loss could not establish complete protection; whether deeper damage actually continues would remain a separate outcome.
- Deeper damage stops but immune protection remains impaired Stopping damage from spreading and restoring defenses against microbes could have different outcomes. If deeper injury ceased while protective secretion remained impaired, water retention and tissue recovery would still not establish full immune recovery.
The proposed chain begins with impaired release of substances involved in water retention and protection against microbes. If restoring water retention also corrects the relevant protective failure, deeper injury could stop along with the improvement in water loss. If protective secretion remains impaired, a normal water-loss measurement could coexist with unresolved vulnerability; this is the possibility being asked about, not an outcome demonstrated by the supplied sources. Treating water loss as proof of complete recovery could therefore misclassify skin protection, while assuming persistent vulnerability without measuring it could also misclassify recovery.
Карты потери воды, RL-3, измеряют водный барьер; поверхностная протеомика, RL-2, не устанавливает полноценность иммунной защиты и восстановления дермы.
Иммунная защита ограничивает последствия барьерного дефекта за заданные часы и дни; вовлечение дермы и остаточное повреждение остаются ниже допустимых границ.
Не установлено, означает ли нормализация потери воды устранение причины каскада или лишь коррекцию одного проявления общего секреторного нарушения.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Проверяемая гипотеза: после сочетания сухости, мытья и трения химическая среда поверхности кожи одновременно снижает активность нескольких секретированных противомикробных пептидов. Повышенная ионная сила ослабляет их бактерицидное действие, хотя количество пептидов, их созревание и секреция остаются нормальными. Липидная коррекция возвращает потерю воды в допустимый диапазон, но не обязательно нормализует эту среду. Общая физико-химическая уязвимость защитных молекул позволяет микробной нагрузке сохраняться и поддерживать повреждение дермы. Нормализация условий действия пептидов должна стабилизировать SPV_6.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Инженерия надёжности и проектирование резервирования: модель отказа по общей причине вместе с вероятностной моделью «нагрузка превышает защитную способность». Для заранее заданного интервала испытания Q = P[G > K1(S) + K2(S) + K12(S)]. Q означает вероятность увеличения жизнеспособной микробной нагрузки; G означает скорость роста бактерий без исследуемых защитных компонентов; S означает измеренную ионную силу поверхностной среды; K1(S) и K2(S) означают измеренные скорости подавления роста двумя защитными компонентами, например LL-37 и человеческим β-дефензином-2; K12(S) означает дополнительный эффект их сочетания, положительный при синергии и отрицательный при антагонизме. G и все K выражают в одинаковых единицах изменения log10 жизнеспособной микробной нагрузки за час. Вероятность оценивают по распределению этих величин между образцами и циклами. S выступает общей причиной снижения обеих защитных составляющих, поэтому их нельзя считать независимыми резервами. Инженерный принцип изложен в [документе NRC об отказах по общей причине](https://www.nrc.gov/regulations-legislation/nureg-series-publications/publications-prepared-by-nrc-staff/sr2225). Включение K12 обязательно: синергия LL-37 и β-дефензина-2 против S. aureus наблюдалась в [экспериментальном исследовании](https://www.nejm.org/doi/full/10.1056/NEJMoa021481). Уравнение представляет проверяемую адаптацию инженерной модели, а не установленный закон кожи.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковых потере воды, липидном составе, кислотности и количестве секретированных пептидов противомикробная активность должна восстанавливаться после нормализации ионной силы без усиления секреции. Обратное изменение солевого состава должно воспроизводить потерю активности в бесклеточной пробе. В модели кожи это восстановление должно предшествовать снижению жизнеспособной микробной нагрузки и уменьшению повреждения дермы. Усиление секреции пептидов с одинаковой чувствительностью к солевой среде даст меньший эффект, чем добавление независимо проверенного защитного компонента, сохраняющего активность в этой среде. Если измеренный солевой состав не снижает активность пептидов либо его нормализация не улучшает уничтожение бактерий, гипотеза опровергается.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable restoration and loss of antimicrobial activity under stated conditions, plus explicit rejection criteria. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Сначала проверяют активность поверхностных образцов в исходной среде и после контролируемой замены солевого состава с сохранением концентрации белков. Отдельно измеряют прямое влияние солей на рост бактерий в отсутствие пептидов. Осмотические эффекты отделяют от ионных с помощью подходящего неионного контроля. Затем проверяют причинную связь с повреждением дермы в модели человеческой кожи. Солевая чувствительность LL-37 показана экспериментально, но её достаточность для данного возрастного нарушения остаётся гипотезой. [Исследование активности LL-37](https://pubmed.ncbi.nlm.nih.gov/9736536/).
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковых потере воды, липидном составе, кислотности и количестве секретированных пептидов противомикробная активность должна восстанавливаться после нормализации ионной силы без усиления секреции. Обратное изменение солевого состава должно воспроизводить потерю активности в бесклеточной пробе. В модели кожи это восстановление должно предшествовать снижению жизнеспособной микробной нагрузки и уменьшению повреждения дермы. Усиление секреции пептидов с одинаковой чувствительностью к солевой среде даст меньший эффект, чем добавление независимо проверенного защитного компонента, сохраняющего активность в этой среде. Если измеренный солевой состав не снижает активность пептидов либо его нормализация не улучшает уничтожение бактерий, гипотеза опровергается.
- What would separate them
Restored skin lipids may feed bacterial growth and prolong deeper skin damage predicts: В модели человеческой кожи с иммунным компонентом сравнивают липидное восстановление и контроль с одинаковыми потерей воды, гидратацией, кислотностью и ионной силой среды. При одинаковой исходной микробной нагрузке липидное восстановление должно увеличивать включение изотопной метки жирных кислот в бактериальные фосфолипиды, чистый прирост жизнеспособных бактерий и последующее повреждение дермы. Этот дополнительный эффект должен исчезать при нарушении бактериального использования внешних жирных кислот и возвращаться после восстановления соответствующей функции. Сравнивают взаимодействие «липидное восстановление × бактериальная способность использовать липиды», учитывая самостоятельное влияние генетического изменения на рост и вирулентность. Отсутствие такого взаимодействия при подтверждённом включении метки опровергнет причинную роль усвоения липидов. Нормализация ионной среды без изменения липидного потока, согласно этой гипотезе, не устранит дополнительный рост.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.